SCHEMBL2037835

SCHEMBL2037835

NS(=O)(=O)Cc1ccc(C(CC2CCCC2)c2cc3cccnc3[nH]2)cc1

nearest known ligand 0.71

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GCK P35557 20/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1959950 0.86 GCK (0.74) GCK
SCHEMBL1962013 0.85 GCK (0.75) GCK
SCHEMBL2197921 0.84 GCK (0.71) GCK
SCHEMBL27873204 0.84 GCK (0.71) GCK
SCHEMBL2199152 0.84 GCK (0.73) GCK
SCHEMBL2347451 0.84 GCK (0.71) GCK
SCHEMBL1959078 0.83 GCK (0.70) GCK
SCHEMBL2195760 0.83 GCK (0.70) GCK
SCHEMBL10819868 0.83 GCK (0.70) GCK
SCHEMBL2196267 0.83 GCK (0.70) GCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2513103-A1 AZAINDOLE GLUCOKINASE ACTIVATORS F. Hoffmann-La Roche AG (CH) 2012-10-24 EP disclosed
WO-2011073117-A1 AZAINDOLE GLUCOKINASE ACTIVATORS F. HOFFMANN-LA ROCHE AG (CH) 2011-06-23 WO disclosed